Skip to main content
Mon Devis Facile Kezako logo

Mon Devis Facile Kezako

Security and trust center evidence

Kezako offers an alternative to unreliable freelancers and costly agencies by providing UI UX design, branding, and Webflow website

kezako.ioDesign toolsLast verified 17 Sep 2026

Summary

Mon Devis Facile Kezako has , and 1 expired in the CertReports index, last verified 17 Sep 2026. The strongest row is EU-US Data Privacy Framework: Inactive. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 17 Sep 2026, CertReports holds 1 expired row for Mon Devis Facile Kezako, drawn from the Data Privacy Framework list. Mon Devis Facile Kezako previously appeared with EU-US Data Privacy Framework evidence, but the listing is no longer active and CertReports found no renewal as of 17 Sep 2026. No public evidence was found for SOC 2, ISO/IEC 27001, HIPAA and GDPR as of 17 Sep 2026; that is a gap in the public record, not a finding of non-coverage, and the vendor can supply it under NDA.

  • EU-US Data Privacy Framework: Inactive, expired as of 17 Sep 2026

Facts only, each dated; nothing here is inferred, scored or advised.

Among design tools vendors

0verified rows

Category median 0, across 27 indexed design tools vendors. Mon Devis Facile Kezako has no registry-verified row yet, like 63 percent of them; its evidence is vendor-stated or reported.

brandingdesign subscriptionui ux designweb designwebflow development

Compliance grid

No public evidence yet for HIPAA, SOC 2, GDPR, FedRAMP, PCI DSS, ISO 27001, CSA STAR, Cyber Essentials, ISO 27701, ISO 42001. This does not mean the vendor lacks them; it means nothing public was found at the last check.

Subprocessors

No subprocessor list captured yet.

Change history

  1. 18 Sep 2026First indexed by CertReports1 evidence row across 1 framework entered the index.

Similar vendors with evidence

Related by product tags and the Design tools category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.